Dr Reddys Laboratories
Family companies weathering Covid-19 pandemic storm better than peers
Dr Reddy's Labs looks to recover from Q1 blues with multiple growth drivers
Dr Reddy's unit fails to get compliance certificate from German regulator
USFDA issues alert on Dr Reddy's Hyderabad unit
Dr Reddy's Lab down 5% to hit 52-week low, top Sensex loser

Dr Reddy's hits 52-week low on USFDA observations at Duvvada unit
Dr Reddys Lab dips on disappointing Q1 earnings
Dr Reddys Lab trades weak ahead of Q1 results